Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Sherene Loi
Based on 99 articles published since 2010
(Why 99 articles?)
||||
Expertise Level
The expertise of Sherene Loi ranks in the
  • Top 0.011%
  • ... of 274,566 published authors worldwide on Breast Neoplasms
  • ... from 2010 through 2020
  • ... based on contributions to 99 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Peter MacCallum Cancer Centre      
2020
  • Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel. · Department of Pathology, GZA-ZNA, Antwerp, Belgium. · Division of Research, Peter Mac Callum Cancer Center, Melbourne, Australia. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medical Oncology Department, AC Camargo Cancer Center, São Paulo, Brazil. · Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel. · German Breast Group, Neu-Isenburg and Goethe University Frankfurt and Centre for Haematology and Oncology, Bethanien, Frankfurt, Germany. · Institute of Pathology, Philipps-University Marburg and UKGM Marburg, Marburg, Germany. · Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, University of Tampere and Tampere University Hospital, Tampere, Finland. · Department of Computer Science, Ariel University, Ariel, Israel. · Peter MacCallum Cancer Centre, University of Melbourne, Parkville, Victoria, Australia. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP U108, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Pubmed 31904863
2019
  • Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 31384388
  • SA Pathology, Royal Adelaide Hospital, Adelaide, SA, Australia. Electronic address: · Western Sydney University, and Australian Clinical Labs, Sydney, NSW, Australia. · ACT Pathology, Canberra Hospital, and ANU Medical School, Canberra, ACT, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, and the University of Melbourne, Melbourne, Vic, Australia. · The University of Queensland Centre for Clinical Research, and Pathology Queensland Research, Brisbane, Qld, Australia. · Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia. · Medical Oncology, Deakin University, Vic, Australia. · Surgical Oncology, The University of Sydney, and Mater Hospital North Sydney, Sydney, NSW, Australia. · Pubmed 31076089
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 31448088
  • Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132, Genova, Italy. · Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. · Frontier Science, Kingussie, UK. · Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · IEO, European Institute of Oncology IRCCS, University of Milan, Milan, Italy. · Mayo Clinic, Phoenix, AZ, USA. · Breast International Group, Brussels, Belgium. · National Cancer Institute, Bethesda, MD, USA. · Novartis Pharma AG, Basel, Switzerland. · Mayo Clinic, Jacksonville, FL, USA. · Sana Klinikum Offenbach, Offenbach, Germany. · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. · Institut Gustave Roussy, Villejuif, France. · Champalimaud Clinical Center, Champalimaud Foundation and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain. · Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia. · Pubmed 31134488
  • Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 31839159
  • Matrix Microenvironment & Metastasis Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, VIC, 3084, Australia. · School of Cancer Medicine, La Trobe University, Bundoora, VIC, 3086, Australia. · Metastasis Research Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia. · Metastasis Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Florey Institute of Neuroscience and Mental Health, Parkville, VIC, 3052, Australia. · Puma Biotechnology, Inc., 10880 Wilshire Blvd, Los Angeles, CA, 90024, USA. · Translational Breast Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Peter MacCallum Cancer Centre, Moorabbin Campus, East Bentleigh, VIC, 3165, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, 3000, Australia. · Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, 3000, Australia. · Royal College of Surgeons, Dublin, D02 YN77, Ireland. · Tumour Progression and Heterogeneity Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia. · Molecular Medicine Division, The Walter and ELIZA Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. · Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia. · Matrix Microenvironment & Metastasis Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, VIC, 3084, Australia. · School of Cancer Medicine, La Trobe University, Bundoora, VIC, 3086, Australia. · Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, 3000, Australia. · Pubmed 31409375
  • Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Ballarat Health Services, Ballarat, VIC, Australia. · St George Private Hospital, Kogarah, NSW, Australia. · St George Hospital and Sutherland Hospitals, Kogarah, NSW, Australia. · Royal Hobart Hospital, Hobart, TAS, Australia. · The Canberra Hospital, Woden, ACT 2606 and Australian National University Medical School, Garran, ACT, Australia. · Western Private Hospital, Footscray, VIC, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia. · Pubmed 31321873
  • Department of Sports Cardiology, Baker Heart and Diabetes Institute, Melbourne VIC, AUSTRALIA. · Institute for Physical Activity and Nutrition, Deakin University, Geelong, VIC, AUSTRALIA. · Exercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne VIC, AUSTRALIA. · Melbourne Cancer Care, Cabrini Health, Brighton, VIC, AUSTRALIA. · Translational Breast Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, AUSTRALIA. · Department of Cardiovascular Sciences, KU Leuven, Leuven, BELGIUM. · Integrated Cardiovascular Exercise Physiology and Rehabilitation (iCARE) Laboratory, College of Nursing and Health Innovation, University of Texas Arlington, Arlington, TX. · Cardiology Department, St Vincent's Hospital Melbourne, Melbourne VIC, AUSTRALIA. · Pubmed 30829962
  • Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia. · The Royal Melbourne and Royal Women's Hospitals, Parkville, Victoria, Australia. · The Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Bioinformatics Consulting Core, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Genomics Core, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, Victoria, Australia. · Lifepool, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia. · Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia. · Cancer Genetics and Genomics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 30746706
  • 1 Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · 2 Gustave Roussy, Université Paris-Saclay, Villejuif, France. · 3 Université Paris-Sud, Institut National de la Santé et de la Recherche Médicale, Villejuif, France. · 4 New York University School of Medicine, New York, NY. · 5 Fondazione Istituto di Ricovero e Cura a Carattere Scientifico-Isituto Nazionale dei Tumori, Universita degli Studi di Milano, Milan, Italy. · 7 Helsinki University Central Hospital, Helsinki, Finland. · 8 University of Padova, Padova, Italy. · 9 Veneto Insitute of Oncology-IOV-IRCCS, Padua, Italy. · 10 Indiana University, Indianapolis, IN. · 11 Weill-Cornell Medicine, New York, NY. · 12 Dana-Farber Cancer Institute, Boston, MA. · 13 European institute of Oncology, Milan, Italy. · 6 R&D UNICANCER, Paris, France. · 14 Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · 15 Tampere University Hospital, Tampere, Finland. · 16 University of Milan, Milan, Italy. · 17 Charite Universite Hospital, Berlin, Germany. · 18 GZA, Antwerp, Belgium. · Pubmed 30650045
  • Cancer Care Centre, St George Hospital, Sydney, NSW, Australia. · National Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW, 1450, Australia. · Division of Hematology and Oncology, Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, CA, USA. · Garvan Institute of Medical Research and St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Prince of Wales Hospital, Sydney and Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia. · Cancer Care Centre, St George Hospital, Sydney, NSW, Australia. · National Health and Medical Research Council (NHMRC) Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW, 1450, Australia. · Pubmed 30465154
  • Peter MacCallum Cancer Centre, Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 31591582
2018
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia. · Pubmed 29156891
  • Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Department of Pathology/GZA, Antwerp, Belgium. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · University of Melbourne, Melbourne, VIC, Australia. · Pubmed 29808015
  • Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy; Medical Oncology 2, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy. Electronic address: · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/University of Auvergne U1240, Clermont-Ferrand, France. · Montefiore Medical Center, Bronx, NY, USA; The Albert Einstein College of Medicine, Bronx, NY, USA. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Department of Pathology, GZA Ziekenhuizen, Antwerp, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, B2 M, RdC,114 rue Edouard-Vaillant, 94805, Villejuif, France; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, 94805, France. · Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France; Inserm/University of Auvergne U1240, Clermont-Ferrand, France; School of Medicine, University of Auvergne, Clermont-Ferrand, France. · Division of Pathology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. · Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA. · Department of Research, Instituto Nacional de Enfermedades Neoplasicas, Lima 15038, Peru. · Department of Pathology and Laboratory, Medicine, Indiana University, Indianapolis, USA. · Department of Pathology, Yale University School of Medicine, New Haven, USA. · Pathology Department, IIS, Fundacion Jimenez Diaz, UAM, Madrid, Spain. · Department of Pathology, Coney Island Hospital, NY, USA. · Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. · Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy. · National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA, USA. · Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA. · dlw Laborsoftware UG (haftungsbeschränkt) Lübben, Germany. · German Breast Group, Neu-Isenburg, Germany. · Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, USA. · Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · New York University Medical School, Perlmutter Cancer Center, NY, USA. · Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. · Translational Breast Cancer Genomic and Therapeutics Laboratory, Peter Mac Callum Cancer Center, Victoria, Australia; Breast Cancer Translational Research Laboratory, Jules Bordet Institute, Brussels, Belgium; Department of Pathology, GZA, Antwerp, Belgium. · Pubmed 29024776
  • From the Barts Cancer Institute, Queen Mary University of London, London (P.S.) · Perlmutter Cancer Center, New York University School of Medicine, New York (S.A.) · the Department of Medicine, University of California, San Francisco, San Francisco (H.S.R.), and Genentech, South San Francisco (L.M., S.Y.C., R.F.) - both in California · University Hospital Heidelberg, Heidelberg, Germany (A.S.) · Centro de Pesquisa em Oncologia, Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre (C.H.B.), and the University of São Paulo, São Paulo (R.H.) - both in Brazil · Aichi Cancer Center Hospital, Nagoya, Japan (H.I.) · the Department of Medical Oncology, Institut Curie, Paris (V.D.) · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.) · Florida Cancer Specialists and Research Institute, New Port Richey (G.S.W.) · Roche, Basel, Switzerland (V.H., A.H.) · Dana-Farber Cancer Institute, Boston (E.P.W.) · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S.L.) · and the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore (L.A.E.). · Pubmed 30345906
  • Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, 710 N Fairbanks Ct, Ste 8-250A, Chicago, IL 60611, USA. Electronic address: · University of Pennsylvania Abramson Cancer Center, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA. Electronic address: · Pfizer Italia, Via Anna Maria Mozzoni, 12, 20152 Milano, MI, Italy. Electronic address: · Royal Marsden Hospital and Institute of Cancer Research, Fulham Road, London SW3 6JJ, UK. Electronic address: · David Geffen School of Medicine, 2020 Santa Monica Blvd, Ste 600, Santa Monica, CA 90404, USA. Electronic address: · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongro-gu, Seoul 03080, Republic of Korea. Electronic address: · Breast Oncology, NHO Osaka National Hospital, 2 Chome-1-14 Hoenzaka, Chuo, Osaka, Osaka Prefecture 540-0006, Japan. Electronic address: · Ottawa Hospital Cancer Centre, 501 Smyth Road, Ottawa, ON, Canada. Electronic address: · Peter MacCallum Cancer Centre, 305 Grattan St., Melbourne, Victoria 3000, Australia. Electronic address: · European Institute of Oncology, Via Ripamonti, 435, 20141, Milan, Italy. Electronic address: · Pfizer Inc, 300 Technology Square, Cambridge, MA 02139, USA. Electronic address: · Pfizer Oncology, 10555 Science Center Drive, San Diego, CA 92121, USA. Electronic address: · Pfizer Oncology, 10555 Science Center Drive, San Diego, CA 92121, USA. Electronic address: · Pfizer Oncology, 500 Arcola Rd, Collegeville, PA 19426, USA. Electronic address: · Pubmed 30308388
  • Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Breast Unit, Royal Marsden Hospital, London, United Kingdom. · Pfizer, New York, New York. · Tumour Profiling Unit, The Institute of Cancer Research, London, United Kingdom. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · German Breast Group, Neu-Isenburg, Germany. · Division of Research and Cancer Medicine, University of Melbourne, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois. · Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Pubmed 30206110
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia. · International Breast Cancer Study Group, Coordinating Center, Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group, Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Basel, Switzerland. · Breast Center, Cantonal Hospital, St Gallen, Switzerland. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 29902286
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Medical Oncology, Institut Claudius Regaud, Oncolpole-Toulouse, France. · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Medical Oncology, UHN Princess Margaret Cancer Centre, Toronto, ON, Canada. · Breast and GYN Early Trials Program, Scottsdale Healthcare Shea Medical Center, Scottsdale, Arizona. · Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France, INSERM U900 Research Unit, Saint-Cloud France, and Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Drug Development Department, Gustave Roussy, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Department of Clinical Oncology, Merck & Co., Inc., Kenilworth, New Jersey. · Division of Medical Oncology, Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. · Pubmed 29559561
  • Department of Medicine and. · Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Pathology, University of California, San Diego, San Diego, California, USA. · Department of Pathology Microbiology, and Immunology, and. · Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium. · Department of Oncology, University of Melbourne and Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Clearview Cancer Institute, Huntsville, Alabama, USA. · Departments of Pathology and Medicine, Yale University, New Haven, Connecticut, USA. · Navigate BioPharma Services Inc., a Novartis Company, Carlsbad, California, USA. · Department of Medicine, Northwestern University, Chicago, Illinois, USA. · Departments of Medicine, Microbiology, and Biochemistry and Molecular Genetics, University of Alabama, Birmingham, Alabama, USA. · Pubmed 30568030
  • Peter MacCallum Cancer Centre, and the Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 30413380
  • Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Unit of Surgical Pathology, Fondazione del Piemonte per l'Oncologia, Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC 3000, Australia. · START, 4383 Medical Dr, San Antonio, TX 78229, USA. · Puma Biotechnology Inc., 10880 Wilshire Blvd, Los Angeles, CA 90024, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · START Madrid, Centro Integral Oncológico Clara Campal, Hospital Universitario Madrid Sanchinarro, Calle de Oña 10, 28050 Madrid, Spain. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 30301790
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia. · Service de Biostatistique et D'Epidémiologie, Gustave Roussy, CESP, U1018, Université Paris-Sud, Faculté de Médcine, Université Paris-Saclay, Villejuif, France. · Department of Medicine, Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 30169535
  • Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia. · School of Medicine, Tsinghua University, Beijing, China. · Department of Mathematics and Statistics, La Trobe University, Melbourne, Victoria, Australia. · Department of Pathology, GZA Ziekenhuizen, Antwerp, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Surgery Royal Melbourne Hospital and Royal Womens' Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Melbourne, Victoria, Australia. · Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 29942092
  • Breast Medical Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. · Computational Biology and Bioinformatics Program, Yale University, New Haven, Connecticut. · Institute for Computational Biomedicine, Department of Physiology and Biophysics, Weill Cornell Medical College, New York, New York. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Center, East Melbourne, Victoria, Australia. · Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Department of Obstetrics and Gynecology, University of Munich, Munich, Germany. · Novartis AG, Basel, Switzerland. · Department of Oncology, Istituto Nazionale Tumori, Milan, Italy. · Department of Obstetrics and Gynecology, University of Ulm, Ulm, Germany. · Breast Medical Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medical College, New York, New York. · Pubmed 29902299
  • J.C. Heuson Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Department of Pathology, GZA Ziekenhuizen, Campus Sint Augustinus, Wilrijk, Belgium. · Unit of Medical Statistics, Biometry and Bioinformatics "Giulio A. Maccacaro," Department of Clinical Sciences and Community Health, University of Milan Campus, Cascina Rosa, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. · Division of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Internal Medicine (DiMI), University of Genoa and IRCCS San Martino-National Cancer Institute, Genoa, Italy. · Department of Pathology, Cliniques Universitaires Saint Luc, Brussels, Belgium. · Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France. · Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sandro Pitigliani Medical Oncology Unit, Hospital of Prato, Instituto Toscano Tumori, Prato, Italy. · Academic Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK. · Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK. · Department of Pathology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Pubmed 29471435
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia; Department of Pathology/GZA, Antwerp, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 29233560
2017
  • Hospital Sirio Libanes, Adma Jafet St 91, 1308050 São Paulo, Brazil. · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Centro Cellex, Calle Natzaret 115-117, 08035 Barcelona, Spain. Electronic address: · European Institute of Oncology, Via Ripamonti 435, 20146 Milano, Italy. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Grattan Street 305, 3000 Melbourne, Australia. Electronic address: · Institute of Pathology, Charité Universitätsmedizin Berlin and German Cancer Consortium (DKTK), Campus Mitte, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Baselga Oncological Institute, Quiron Hospital, Plaça d'Alfonso Comín 5, 08023 Barcelona, Spain. Electronic address: · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Baselga Institute of Oncology, Madrid, Spain. Electronic address: · Pubmed 29061314
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA Ziekenhuizen, Antwerp, Belgium. · University of Melbourne, Melbourne, VIC, Australia. · Pubmed 28824872
  • Peter MacCallum Cancer Centre, Melbourne, Australia. · Peter MacCallum Cancer Centre, Melbourne, Australia; University of Melbourne, Melbourne, Australia. Electronic address: · Pubmed 28668293
  • Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, 305 Grattan St, Melbourne, Victoria, 3000, Australia. · Sir Peter MacCallum, Department of Oncology, University of Melbourne, Parkville, 3010, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, 305 Grattan St, Melbourne, Victoria, 3000, Australia. · Sir Peter MacCallum, Department of Oncology, University of Melbourne, Parkville, 3010, Australia. · Pubmed 28534250
  • German Breast Group, Neu-Isenburg, Germany; Sana-Klinikum Offenbach, Germany. Electronic address: · SOLTI Breast Cancer Research Group, Barcelona, Spain. · German Breast Group, Neu-Isenburg, Germany. · Breast International Group, Brussels, Belgium. · Gustave Roussy, Service de Biostatistique et d'Epidémiologie, Villejuif, France; CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Institute of Pathology, Charité University Hospital, Berlin, Germany. · Luisenkrankenhaus Düsseldorf, Germany. · Hospital Clinico Universitario de Valencia, Spain. · Helios Klinikum Berlin-Buch, Department of Obstetrics and Gynaecology, Berlin, Germany. · Department of Haematology-Oncology, National University Cancer Institute, Singapore. · Novartis Pharma SAS, Rueil Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Kliniken Essen-Mitte, Essen, Germany. · Department of Internal Medicine I, Division of Oncology, Medical University of Vienna, Austria; Comprehensive Cancer Center Vienna, Austria. · Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium. · University Breast Centre of Franconia, OBGYN Department, University Hospital Erlangen, CCC Erlangen-EMN, Germany. · Breast International Group, Brussels, Belgium; Université Libre de Bruxelles, Institut Jules Rue Héger-Bordet 1, Medical Oncology Clinic, Belgium. · SOLTI Breast Cancer Research Group, Barcelona, Spain; Memorial Sloan-Kettering Cancer Center, New York, USA. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Australian New Zealand Breast Cancer Trials Group (ANZBCTG), Newcastle, Australia. Electronic address: · Pubmed 28923573
  • German Breast Group GBG Forschungs GmbH, Neu-Isenburg, Germany · Centre for Haematology and Oncology Bethanien, Frankfurt, Germany. · Royal Marsden Hospital and Institute of Cancer Research, London, UK. · National Cancer Center, Goyang-si, South Korea. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA. · Aichi Cancer Center Hospital, Nagoya, Japan. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. · Breast Oncology, NHO Osaka National Hospital, Osaka-city, Japan. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Institut Gustave Roussy, Villejuif, France. · Brustzentrum der Universität München (LMU), Munich, Germany. · University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada. · Pfizer Oncology, Cambridge, Massachussets, USA. · Pfizer Inc., San Diego, California, USA. · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pubmed 28652278
  • EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · EORTC, Medical Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Department of Medical Oncology, Institut Bergonié Unicancer, INSERM CIC1401, Bordeaux, France. Electronic address: · Western General Hospital, Edinburgh Cancer Centre, Crewe Road South, GB Edinburgh EH4 2XU, UK. Electronic address: · EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 28027521
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA-Hospitals, Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Genentech, South San Francisco, CA, USA. · Roche Products, Welwyn, UK. · Oncology Biomarker Development, Roche, Basel, Switzerland. · Lombardi Comprehensive Cancer Centre, Georgetown University, Washington, DC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 27964843
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Surgery, St. Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28947417
  • Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, 1000, Belgium. · Breast Cancer Research Program and Department of Medicine, Vanderbilt-Ingram Cancer Centre and Vanderbilt University Medical Centre, Nashville, TN, 37232, USA. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Pubmed 28928458
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. · Institut du Cancer de Montréal, Montréal, Québec, Canada. · Faculté de Pharmacie, Université de Montréal, Québec, Canada. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. · Pubmed 28855210
  • Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia. · Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Department of Immunology, Monash University, Clayton, Victoria, Australia. · Garvan Institute of Medical Research, Darlinghurst, Sydney, Australia. · St. Vincent's Hospital, University of New South Wales, Darlinghurst, Sydney, Australia. · Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia. · Pubmed 28848054
  • Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Molecular Genetics of Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Immunotherapy Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Parkville Integrated Familial Cancer Centre, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. · Department of Medicine, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28592566
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
  • Department of Pathology, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Department of Pathology, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Molecular Genomics Core, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Cancer Genomics Program, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Translational Breast Cancer Research, The Kinghorn Cancer Centre and Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · Department of Anatomical Pathology, South Eastern Area Pathology Service, St George Hospital, Kogarah, NSW, Australia. · School of Medical Sciences, University of New South Wales, Kensington, NSW, Australia. · Discipline of Pathology, School of Medicine, University of Western Sydney, Campbelltown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Cancer Pathology, Bosch Institute, University of Sydney, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Camperdown, NSW, Australia. · School of Medicine and UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Australia. · Breast Service, The Royal Melbourne and Royal Women's Hospitals, Parkville, VIC, Australia. · Department of Surgery, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Translational Genomics &Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia. · Pubmed 28338653
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. Electronic address: · Pubmed 28049579
2016
  • Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 26755511
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Institut Jules Bordet, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 27481651
  • Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia. · Write Source Medical Pty Ltd, Sydney, New South Wales, Australia. · Deakin University, Warun Ponds, Victoria, Australia. · Mater Health Services/Mater Research Institute, South Brisbane, Queensland, Australia. · Wesley Medical Centre and University of Queensland, Queensland, Australia. · Royal Melbourne Hospital, Parkville, Victoria, Australia. · Peter MacCallum Cancer Centre, Victoria, Australia. · Fiona Stanley Hospital, Perth, Western Australia, Australia. · Pubmed 27001208
  • Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, East Melbourne, Victoria 8006, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels 1000, Belgium. · Institute of Pathology, Charité University Hospital, and German Cancer Consortium (DKTK), Charitéplatz 1, Berlin 10117, Germany. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland 4006, Australia. · Pubmed 26667975
  • University of Calgary, Alberta, Canada · Pfizer Inc., Collegeville, Pennsylvania, USA. · Pfizer Inc., New York, New York, USA. · University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · National Cancer Center, Goyang-si, Republic of Korea. · Istituto Europeo di Oncologia, Milan, Italy. · Aichi Cancer Center Hospital, Nagoya, Japan. · Brustzentrum der Universität München, Munich, Germany. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois, USA. · Pfizer Inc., San Diego, California, USA. · Pfizer Inc., Cambridge, Massachusetts, USA. · Institute of Cancer Research and Royal Marsden Hospital, London, United Kingdom. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Pubmed 27368881
  • Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, IL, USA. Electronic address: · Institute of Cancer Research and Royal Marsden Hospital, London, UK. · Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital #4, Dnipropetrovsk, Ukraine. · National Cancer Center, Goyang-si, South Korea. · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. · NHO Osaka National Hospital, Osaka, Japan. · Istituto Europeo di Oncologia, Milan, Italy. · Center for Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sunnybrook Odette Cancer Centre, Toronto, ON, Canada; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada. · Aichi Cancer Center Hospital, Nagoya, Japan. · Brustzentrum der Universität München (LMU), Munich, Germany. · Pfizer, San Diego, CA, USA. · Pfizer, Cambridge, MA, USA. · Pfizer, Collegeville, PA, USA. · Pfizer, New York, NY, USA. · University of California, Los Angeles, Los Angeles, CA, USA. · Pubmed 26947331
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Victoria, Australia. · Cancer Genomics Program, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, London, United Kingdom. · The Francis Crick Institute, London, United Kingdom. · University of Applied Sciences Koblenz, RheinAhrCampus Remagen, Department of Mathematics and Technology, Remagen, Germany. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28027312
  • Oncology Experimental Therapeutics, IRCCS Clinical and Research Institute Humanitas, Via Manzoni 113, 20089, Rozzano-Milan, Italy. · Department of Oncology, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Pathology, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Surgery, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Humanitas University, Rozzano-Milan, Italy. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Immunology and Inflammation, IRCCS Clinical and Research Institute Humanitas, Rozzano-Milan, Italy. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Oncology Experimental Therapeutics, IRCCS Clinical and Research Institute Humanitas, Via Manzoni 113, 20089, Rozzano-Milan, Italy. · Pubmed 27912781
  • Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · German Cancer Consortium, (DKTK), Berlin, Germany. · Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. · Department of Pathology, Center for Integrated Diagnostics (CID), Massachusetts General Hospital, Boston, MA, USA. · Hämatoonkologische Schwerpunktpraxis, Munich, Germany. · Department of Gynecology and Obstetrics, University Hospital Schleswig-Hostein, Kiel, Germany. · Praxisklinik Krebsheilkunde für Frauen/Brustzentrum, Berlin, Germany. · Department of Gynecology and Obstetrics, Charité Universitätsmedizin Berlin, Berlin, Germany. · Institute of Pathology, Technical University Munich, Munich, Germany. · Center for Hematology and Oncology Bethanien, Frankfurt/Main, Germany. · Breast Unit, Kliniken Essen Mitte, Essen, Germany. · Department of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Department of Gynecology, Klinikum Südstadt Rostock, Rostock, Germany. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Department of Gynecology and Obstetrics, Helios Klinikum Berlin-Buch, Berlin, Germany. · German Breast Group c/o (GBG Forschungs GmbH), Neu-Isenburg, Germany. · Pubmed 27611952
  • Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany. · German Cancer Consortium (DKTK), Partner site Berlin, Berlin, Germany. · VMscope GmbH, Berlin, Germany. · Service de Biostatistique et d'Epidémiologie; Institute Gustave Roussy, Villejuif, France. · German Breast Group (GBG), Neu-Isenburg, Germany. · Clinic of Gynecology and Obstetrics, Sana Klinikum Offenbach, Offenbach, Germany. · Indiana University School of Medicine, Indianapolis, IN, USA. · Clinical Institute of Pathology, Medizinische Universität Wien, Wien, Austria. · Department of Pathology & Molecular Medicine, McMaster University, Hamilton, ON, Canada. · Weill Cornell Medical College, Doha, Qatar. · Harvard Medical School, Boston, MA, USA. · Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland. · Institut für Pathologie, Medizinische Hochschule Hannover, Hannover, Germany. · Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk, Belgium. · Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Department of Pathology and Cytology GZA Hospitals, Wilrijk, Belgium. · Department of Pathology University Hospitals Leuven, Leuven, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Anatomical Pathology, Vancouver Hospital, Vancouver, BC, Canada. · Division of Pathology, NSABP, Pittsburgh, PA, USA. · Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada. · UQ School of Medicine and Pathology Queensland, The University of Queensland Centre for Clinical Research, Brisbane, QLD, Australia. · ERTICa Research Team, Department of Pathology, Jean Perrin Comprehensive Cancer Center, University of Auvergne EA4677, Clermont-Ferrand, France. · Division of Pathology and Laboratory Medicine, University of Milan, Milan, Italy. · Department of Pathology, Yale University School of Medicine, New Haven, CT, USA. · Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Department for Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Sektion Gynäkopathologie, Pathologisches Institut, University of Heidelberg, Heidelberg, Germany. · Anatomie Pathologique, Institut Jules Bordet, Brussels, Belgium. · Molecular Diagnostic Oncology, Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Department of Pathology, European Institute of Oncology, University of Milan, Milan, Italy. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Jules Bordet Institute, Brussels, Belgium. · Department of Gynecology, Helios-Klinikum Berlin-Buch, Berlin, Germany. · Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen EMN, Friedrich-Alexander University Erlangen, Erlangen, Germany. · Department of Gynecology, Klinikum Südstadt Rostock, Rostock, Germany. · Molecular Immunology Unit, Institut Jules Bordet, Brussels, Belgium. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Univ. Paris Sud, Univ. Paris-Saclay, Villejuif, France. · Division of Research and Clinical Medicine, Peter MacCallum Cancer Center, Melbourne, VIC, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Brussels, Belgium. · Pubmed 27363491
  • Department of Oncology, Military Institute of Medicine, Szaserów St 128, 04-141, Warsaw, Poland. · Department of Pathology, Medical University of Gdańsk, 7 Dębinki St, 80-211, Gdańsk, Poland. · Department of Oncology, Regional Oncology Center, 66a Katowicka St, 45-060, Opole, Poland. · Department of Neurosurgery, Oncology Center-Institute, 5 Roentgena St, 02-781, Warsaw, Poland. · Department of Neurosurgery, Medical University of Lublin, 1 Al. Racławickie, 20-059, Lublin, Poland. · Department of Oncology, Regional Oncology Center, 12 Ogrodowa St, 15-027, Białystok, Poland. · Department of Pathology, Oncology Center-Institute, 5 Roentgena St, 02-781, Warsaw, Poland. · Department of Neurosurgery, Regional Hospital, 18 Żołnierska St, 10-561, Olsztyn, Poland. · Department of Oncology, Regional Oncology Center, 62 Pabianicka St, 93-513, Łódź, Poland. · Department of Pathology, Military Institute of Medicine, Szaserów St 128, 04-141, Warsaw, Poland. · Department of Oncology and Radiotherapy, Medical University of Gdańsk, 7 Dębinki St, 80-211, Gdańsk, Poland. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, Locked Bag 1, A'Beckett Street, East Melbourne, VIC, 8006, Australia. · Pubmed 27117582
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Frontier Science Foundation- Hellas, Athens, Greece3University of Athens, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece4Athens University of Economics and Business, Athens, Greece. · Frontier Science Foundation- Hellas, Athens, Greece. · Avera Cancer Institute, Department of Molecular and Experimental Medicine, Sioux Falls, South Dakota. · Department of Pathology, University of Chicago, Chicago, Illinois. · BREAST Datacentre, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · University of Milan, European Institute of Oncology, Milan, Italy. · Targos Molecular Pathology GmbH, Kassel, Germany. · Department of Medicine, Institute Jules Bordet, Universite Libre de Bruxelles and Breast International Group (BIG), Brussels, Belgium12Breast International Group (BIG), Brussels, Belgium. · Royal Marsden Hospital, London, England. · INSERM U1018 CESP, Service de Biostatistique et d'Epidémiologie, Villejuif, France. · Pubmed 27100299
  • Chee Khoon Lee, Lucy Davies, Val J. Gebski, Sarah J. Lord, Ian Marschner, and John Simes, University of Sydney · Sarah J. Lord, University of Notre Dame · Ian Marschner, Macquarie University · Paul de Souza, University of Western Sydney, Sydney, New South Wales · Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia · Angelo Di Leo, Hospital of Prato, Istituto Toscano Tumori, Italy · Stephen Johnston, Royal Marsden Hospital, London · David Cameron, University of Edinburgh, Edinburgh, United Kingdom · Charles Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA · Michael F. Press, University of Southern California, Los Angeles, CA · and Catherine Ellis, GlaxoSmithKline, Collegeville, PA. · Pubmed 26811533
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Victoria, Australia. · Service de Biostatistique et d'Epidemiologie, Gustave Roussy, Villejuif, France. INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Department of Oncology, Tampere University Hospital and Tampere University, Tampere, Finland. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Pubmed 26744522
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, Department of Pathology, GZA Antwerp, Belgium. · Charité University and German Cancer Consortium (DKTK), Berlin, Germany. · Departments of Pathology and Medicine, Yale University, New Haven, Connecticut. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Foundation Medicine, Cambridge, Massachusetts. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Maine Medical Center Research Institute, Scarborough, Maine. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Pubmed 26515496
  • Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Australia. · Division of Systems Biology and Personalised Medicine, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Lautenberg Centre, Hebrew University, Jerusalem, Israel. · Division of Medical Genetics, Department of Pediatrics and Neurobiology, Duke University, Durham, North Carolina. · Division of Cell Biology and Molecular Medicine, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, East Melbourne, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia. · St. Vincent's Institute of Medical Research, Melbourne, Victoria, Australia. · Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia. · Research Division, Peter MacCallum Cancer Centre, East Melbourne, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Australia. Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia. · Pubmed 27231202
2015
  • Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pubmed 26300242
  • Department of Medical Oncology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · INSERM Unit U981, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, VIC 3002, Australia. · Department of Biostatistics and Epidemiology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · Department of Medical Oncology and INSERM U916, Institut Bergonié, 229 Cours de l'Argonne, 33000, Bordeaux, France. · Pubmed 26196250
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pathology Dept, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital, Campus Mitte, German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Pubmed 26358523
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
  • Ian J. Majewski, Lorenza Mittempergher, Astrid J. Bosma, and René Bernards, The Netherlands Cancer Institute, Amsterdam, the Netherlands · Paolo Nuciforo, Jose Jimenez, Claudia Aura, Ludmila Prudkin, Maria Carmen Díaz-Delgado, Vall D'Hebron Institute of Oncology · Lorena de la Peña, Spanish Breast Cancer Cooperative Group SOLTI, Barcelona, Spain · Holger Eidtmann, University Hospital Kiel, Kiel · Nadia Harbeck, University of Munich, Munich, Germany · Eileen Holmes, Frontier Science Scotland, Kincraig, United Kingdom · Christos Sotiriou, Debora Fumagalli, and Martine Piccart-Gebhart, Institut Jules Bordet, Université Libre de Bruxelles · Evandro de Azambuja, BrEAST Data Center and Institut Jules Bordet, Brussels, Belgium · Sherene Loi, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia · Catherine Ellis, GlaxoSmithKline, Collegeville, PA · and Nikolaus Schultz and José Baselga, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 25559818
  • Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 26255199
  • Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Multidisciplinary Breast Center, KULeuven, University Hospitals, Leuven, Belgium. · German Breast Group, Neu-Isenburg and Sana-Klinikum, Offenbach, Germany. · Institute of Pathology, Charité Hospital Campus Mitte, and German Cancer Consortium (DKTK), Berlin, Germany. · Department of Oncology, Helsinki University, Hospital and Helsinki University, Helsinki, Finland. · Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pathology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, University of Tampere and Tampere University Hospital, PO Box 607, FIN 33101, Tampere, Finland. · Breast Cancer Translational Research Laboratory J-C Heuson, Institut Jules Bordet, Bld de Waterloo, Université Libre de Bruxelles, 1000, Brussels, Belgium. · Medical Oncology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Bld de Waterloo, 1000, Brussels, Belgium. · Pubmed 26234940
  • U.O. di Patologia Mammaria-Breast Cancer Unit, U.S. Terapia Molecolare e Farmacogenomica, AO-Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Centre for Research on Health and Social Care Management (CeRGAS), Bocconi University, Via Roentgen 1, Milan, Italy. · Yale Cancer Center, Yale School of Medicine, New Haven, CT, United States. · Translational Breast Cancer Genomics and Therapeutics Lab, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Centre Hospitalier Universitaire du Sart Tilman Liege and Liege University, Liège, Belgium. · U.O. di Patologia Mammaria-Breast Cancer Unit, U.S. Terapia Molecolare e Farmacogenomica, AO-Istituti Ospitalieri di Cremona, Viale Concordia 1, 26100, Cremona, Italy. · Department of Policy Analysis and Public Management, Bocconi University, Via Roentgen 1, Milan, Italy. · Pubmed 26044370
  • Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumouri (IRST) - IRCCS, Meldola, Italy. · Department of Internal Medicine, University of Genoa and IRCCS Azienda Ospedaliera Universitaria San Martino - IST, Genoa, Italy. · Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, UK. · Translational Breast Cancer Genomics Lab, Division of Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · VIB Vesalius Research Center, KU Leuven, Campus Gasthuisberg, Herestraat 49, Bus 912, Leuven, Belgium. · Pathology Unit, 'G.B. Morgagni-L. Pierantoni' Hospital, Forlì, Italy. · Breast International Group Headquarters (BIG-aisbl), Brussels, Belgium. · Pathology Department, Jules Bordet Institute, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Medical Oncology, Jules Bordet Institute, Boulevard de Waterloo 121, Brussels, Belgium. · Department of Haematology, University of Cambridge, Cambridge, UK. · Department of Haematology, Addenbrooke's Hospital, Cambridge, UK. · Pubmed 25850943
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy. · Fertility and Procreation Unit, Department of Gynecology Oncology, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 25702955
  • Carsten Denkert, Bruno V. Sinn, Berit M. Pfitzner, Wolfgang D. Schmitt, Silvia Darb-Esfahan, Stephan Wienert, Frederick Klauschen, and Manfred Dietel, Charité Universitätsmedizin Berlin · Carsten Denkert, German Cancer Consortium (DKTK) · Peter Klare, Praxisklinik and Breast Center · Jens-Uwe Blohmer, St Gertrauden Krankenhaus and Charité Universitätsmedizin · Micheal Untch, Helios Klinikum Berlin-Buch, Berlin · Gunter von Minckwitz, Stephan Gade, Keyur Mehta, and Sibylle Loibl, German Breast Group, Neu-Isenburg · Gunter von Minckwitz, Women's Hospital, University of Frankfurt · Hans Tesch, Bethanien Hospital, Frankfurt · Jan C. Brase, Ralf Kronenwett, Karin Fisch, and Kristin Krappmann, Sividon Diagnostics, Cologne · Ralf Kronenwett, Heinrich-Heine University Düsseldorf, Düsseldorf · Christian Schem, Christian-Albrechts Universität zu Kiel, Kiel · Christoph Salat, Onkologische Schwerpunktpraxis, Munich · Marcus Schmidt, Johannes-Gutenberg Universität Mainz, Mainz · Sherko Kümmel, Kliniken Essen-Mitte, Essen · Peter Sinn, University of Heidelberg, Heidelberg · Christian Jakisch and Sibylle Loibl, Sana Klinikum Offenbach, Offenbach · Toralf Reimer, Klinikum Südstadt, Rostock, Germany · Sherene Loi, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia · Sherene Loi and Christos Sotiriou, Institute Jules Bordet, Brussels, Belgium · and Fabrice André, Institute Gustave Roussy, Villejuif, France. · Pubmed 25534375
  • Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Victoria, Australia · Pubmed 25753442
2014
  • Sibylle Loibl, Sana Klinikum, Offenbach · Sibylle Loibl, Gunter von Minckwitz, Sanxing Guo, Stephan Gade, and Valentina Nekljudov, German Breast Group, Neu-Isenburg · Gunter von Minckwitz, Universitäts-Frauenklinik · Fariba Khandan, Agaplesion Markus Krankenhaus · Clemens Heinrichs, OptiPath, Frankfurt · Andreas Schneeweiss and Peter Sinn, Nationales Centrum für Tumorerkrankungen, Heidelberg · Stephan Paepke, Klinikum Rechts der Isar der Technischen Universität, München · Annika Lehmann, Berit Pfitzner, Judith L. Lindner, and Carsten Denkert, Charité Universitätsmedizin · Michael Untch, Helios-Klinikum, Berlin · Mahdi Rezai, Luisenkrankenhaus · Karel Dohnal, Centre for Pathology and Cytology, Düsseldorf · Dirk M. Zahm, SRH Waldklinikum, Gera · Holger Eidtmann, Universitäts-Frauenklinik, Kiel · Jens Huober, Universitäts-Frauenklinik, Ulm · Peter A. Fasching, Universitäts-Frauenklinik, Erlangen · August Dykgers, St Josef Hospital, Dortmund, Germany · Fabrice Andre, Institute Gustave Roussy, Villeueve, France · Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium · and Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 25199759
  • Breast Data Center, Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium; Medical Oncology Department, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, Serbia. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Data Centre, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Pathological Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Department of Medical Oncology, "Sandro Pitigliani" Hospital of Prato, Prato, Italy. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Medical Oncology Department, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Data Center, Institut Jules Bordet, Boulevard de Waterloo 121, Brussels, Belgium. Electronic address: · Breast Cancer Translational Research Laboratory JC Heuson, Institut Jules Bordet, Boulevard de Waterloo 125, Brussels, Belgium; Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Electronic address: · Pubmed 24768477
2013
  • Translational Breast Cancer Genomics Lab; Cancer Therapeutics Program; Peter MacCallum Cancer Centre; St. Andrews Place; East Melbourne, VIC Australia ; Sir Peter MacCallum Department of Oncology; University of Melbourne; Parkville, VIC Australia. · Pubmed 24073365
  • Division of Cancer Medicine and Research, Peter MacCallum Cancer Centre, East Melbourne, VIC 3002, Australia. · Pubmed 23776241
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 23739063
2018
  • From the Institute of Cancer Research and Royal Marsden Hospital, London (N.C.T.) · David Geffen School of Medicine at University of California, Los Angeles, Santa Monica (D.J.S.), and Pfizer Oncology, San Diego (X.H.) - both in California · National Cancer Center, Goyang-si, Gyeonggi-do (J.R.), and Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul (S.-A.I.) - both in South Korea · Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital 4, Dnipropetrovsk, Ukraine (I.B.) · National Hospital Organization Osaka National Hospital, Osaka (N.M.), and Aichi Cancer Center Hospital, Nagoya (H.I.) - both in Japan · Istituto Europeo di Oncologia (M. Colleoni) and Pfizer Oncology (C.G.) - both in Milan · Abramson Cancer Center, University of Pennsylvania, Philadelphia (A.D.), and Pfizer Oncology, Collegeville (C.H.B.) - both in Pennsylvania · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S. Loi) · Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada (S.V.) · Brustzentrum der Universität München, Munich (N.H.), and the German Breast Group, Neu-Isenburg (S. Loibl) - both in Germany · Institut Gustave Roussy, Villejuif, France (F.A.) · Pfizer Oncology, Cambridge, MA (K.P.T.) · and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago (M. Cristofanilli). · Pubmed 30345905
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2015
  • From Royal Marsden Hospital, London (N.C.T.) · National Cancer Center, Goyang-si, South Korea (J.R.) · Institut Gustave Roussy, Villejuif, France (F.A.) · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S. Loi) · Sunnybrook Odette Cancer Centre, Toronto (S.V.) · Aichi Cancer Center Hospital, Nagoya, Japan (H.I.) · Brustzentrum der Universität München, Munich (N.H.), and German Breast Group Forschungs, Neu-Isenburg (S. Loibl) - both in Germany · Pfizer, New York (C.H.B., M.K.), La Jolla, CA (K.Z., S.R.), and Milan (C.G.) · and Thomas Jefferson University, Philadelphia (M.C.). · Pubmed 26030518
2014
  • Translational Breast Cancer Genomics Laboratory, Division of Research, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25290412
  • Division of Research and Clinical Medicine, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Pubmed 25188474
  • Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumDepartment of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxel · Department of MedicineInstitut Jules Bordet, BrEAST Data Centre, Université Libre de Bruxelles (ULB), Boulevard de Waterloo, 121, 1000 Brussels, BelgiumBreast Cancer Translational Research Laboratory (BCTL) J. C. HeusonInstitut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, BelgiumFertility and Procreation UnitDepartment of Gynecologic Oncology, European Institute of Oncology, Milan, ItalyTranslational Breast Cancer Genomic LabCancer Therapeutics Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaSir Peter MacCallum Department of OncologyUniversity of Melbourne, Parkville, Victoria, AustraliaVesalius Research CentreVIB, Leuven, BelgiumLaboratory of Translational GeneticsDepartment of Oncology, University of Leuven, Leuven, BelgiumDepartment of PathologyDivision of Epidemiology and BiostatisticsEuropean Institute of Oncology, Milan, ItalyDepartment of MedicineMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium. · Pubmed 24825746
Probable:    University of Melbourne      
2020
  • Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel. · Department of Pathology, GZA-ZNA, Antwerp, Belgium. · Division of Research, Peter Mac Callum Cancer Center, Melbourne, Australia. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medical Oncology Department, AC Camargo Cancer Center, São Paulo, Brazil. · Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel. · German Breast Group, Neu-Isenburg and Goethe University Frankfurt and Centre for Haematology and Oncology, Bethanien, Frankfurt, Germany. · Institute of Pathology, Philipps-University Marburg and UKGM Marburg, Marburg, Germany. · Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, University of Tampere and Tampere University Hospital, Tampere, Finland. · Department of Computer Science, Ariel University, Ariel, Israel. · Peter MacCallum Cancer Centre, University of Melbourne, Parkville, Victoria, Australia. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP U108, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Pubmed 31904863
2019
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 31448088
  • Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132, Genova, Italy. · Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. · Frontier Science, Kingussie, UK. · Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · IEO, European Institute of Oncology IRCCS, University of Milan, Milan, Italy. · Mayo Clinic, Phoenix, AZ, USA. · Breast International Group, Brussels, Belgium. · National Cancer Institute, Bethesda, MD, USA. · Novartis Pharma AG, Basel, Switzerland. · Mayo Clinic, Jacksonville, FL, USA. · Sana Klinikum Offenbach, Offenbach, Germany. · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. · Institut Gustave Roussy, Villejuif, France. · Champalimaud Clinical Center, Champalimaud Foundation and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain. · Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia. · Pubmed 31134488
  • Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 31839159
  • Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Ballarat Health Services, Ballarat, VIC, Australia. · St George Private Hospital, Kogarah, NSW, Australia. · St George Hospital and Sutherland Hospitals, Kogarah, NSW, Australia. · Royal Hobart Hospital, Hobart, TAS, Australia. · The Canberra Hospital, Woden, ACT 2606 and Australian National University Medical School, Garran, ACT, Australia. · Western Private Hospital, Footscray, VIC, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia. · Pubmed 31321873
  • Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia. · The Royal Melbourne and Royal Women's Hospitals, Parkville, Victoria, Australia. · The Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Bioinformatics Consulting Core, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Genomics Core, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, Victoria, Australia. · Lifepool, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia. · Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia. · Cancer Genetics and Genomics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 30746706
  • 1 Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · 2 Gustave Roussy, Université Paris-Saclay, Villejuif, France. · 3 Université Paris-Sud, Institut National de la Santé et de la Recherche Médicale, Villejuif, France. · 4 New York University School of Medicine, New York, NY. · 5 Fondazione Istituto di Ricovero e Cura a Carattere Scientifico-Isituto Nazionale dei Tumori, Universita degli Studi di Milano, Milan, Italy. · 7 Helsinki University Central Hospital, Helsinki, Finland. · 8 University of Padova, Padova, Italy. · 9 Veneto Insitute of Oncology-IOV-IRCCS, Padua, Italy. · 10 Indiana University, Indianapolis, IN. · 11 Weill-Cornell Medicine, New York, NY. · 12 Dana-Farber Cancer Institute, Boston, MA. · 13 European institute of Oncology, Milan, Italy. · 6 R&D UNICANCER, Paris, France. · 14 Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · 15 Tampere University Hospital, Tampere, Finland. · 16 University of Milan, Milan, Italy. · 17 Charite Universite Hospital, Berlin, Germany. · 18 GZA, Antwerp, Belgium. · Pubmed 30650045
  • Peter MacCallum Cancer Centre, Melbourne, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Pubmed 31591582
2018
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia. · Pubmed 29156891
  • Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Department of Pathology/GZA, Antwerp, Belgium. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · University of Melbourne, Melbourne, VIC, Australia. · Pubmed 29808015
  • From the Barts Cancer Institute, Queen Mary University of London, London (P.S.) · Perlmutter Cancer Center, New York University School of Medicine, New York (S.A.) · the Department of Medicine, University of California, San Francisco, San Francisco (H.S.R.), and Genentech, South San Francisco (L.M., S.Y.C., R.F.) - both in California · University Hospital Heidelberg, Heidelberg, Germany (A.S.) · Centro de Pesquisa em Oncologia, Hospital São Lucas, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre (C.H.B.), and the University of São Paulo, São Paulo (R.H.) - both in Brazil · Aichi Cancer Center Hospital, Nagoya, Japan (H.I.) · the Department of Medical Oncology, Institut Curie, Paris (V.D.) · Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea (S.-A.I.) · Florida Cancer Specialists and Research Institute, New Port Richey (G.S.W.) · Roche, Basel, Switzerland (V.H., A.H.) · Dana-Farber Cancer Institute, Boston (E.P.W.) · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S.L.) · and the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore (L.A.E.). · Pubmed 30345906
  • Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Breast Unit, Royal Marsden Hospital, London, United Kingdom. · Pfizer, New York, New York. · Tumour Profiling Unit, The Institute of Cancer Research, London, United Kingdom. · Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. · German Breast Group, Neu-Isenburg, Germany. · Division of Research and Cancer Medicine, University of Melbourne, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Chicago, Illinois. · Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Pubmed 30206110
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia. · International Breast Cancer Study Group, Coordinating Center, Central Pathology Office, Bern, Switzerland. · International Breast Cancer Study Group, Central Pathology Office, Department of Pathology, European Institute of Oncology, Milan, Italy. · Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Basel, Switzerland. · Breast Center, Cantonal Hospital, St Gallen, Switzerland. · International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, University of Milan, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 29902286
  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California. · Department of Medical Oncology, Institut Claudius Regaud, Oncolpole-Toulouse, France. · Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Medical Oncology, UHN Princess Margaret Cancer Centre, Toronto, ON, Canada. · Breast and GYN Early Trials Program, Scottsdale Healthcare Shea Medical Center, Scottsdale, Arizona. · Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France, INSERM U900 Research Unit, Saint-Cloud France, and Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. · Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Drug Development Department, Gustave Roussy, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Department of Clinical Oncology, Merck & Co., Inc., Kenilworth, New Jersey. · Division of Medical Oncology, Department of Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. · Pubmed 29559561
  • Department of Medicine and. · Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Pathology, University of California, San Diego, San Diego, California, USA. · Department of Pathology Microbiology, and Immunology, and. · Breast Cancer Research Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA. · Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium. · Department of Oncology, University of Melbourne and Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Clearview Cancer Institute, Huntsville, Alabama, USA. · Departments of Pathology and Medicine, Yale University, New Haven, Connecticut, USA. · Navigate BioPharma Services Inc., a Novartis Company, Carlsbad, California, USA. · Department of Medicine, Northwestern University, Chicago, Illinois, USA. · Departments of Medicine, Microbiology, and Biochemistry and Molecular Genetics, University of Alabama, Birmingham, Alabama, USA. · Pubmed 30568030
  • Peter MacCallum Cancer Centre, and the Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 30413380
  • Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Unit of Surgical Pathology, Fondazione del Piemonte per l'Oncologia, Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC 3000, Australia. · START, 4383 Medical Dr, San Antonio, TX 78229, USA. · Puma Biotechnology Inc., 10880 Wilshire Blvd, Los Angeles, CA 90024, USA. · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · START Madrid, Centro Integral Oncológico Clara Campal, Hospital Universitario Madrid Sanchinarro, Calle de Oña 10, 28050 Madrid, Spain. · Unit of Investigative Clinical Oncology (INCO), Candiolo Cancer Institute, FPO-IRCCS, Str. Provinciale 142, 10060 Candiolo, Italy. · Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. · Pubmed 30301790
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast International Group, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia. · Service de Biostatistique et D'Epidémiologie, Gustave Roussy, CESP, U1018, Université Paris-Sud, Faculté de Médcine, Université Paris-Saclay, Villejuif, France. · Department of Medicine, Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 30169535
  • Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia. · School of Medicine, Tsinghua University, Beijing, China. · Department of Mathematics and Statistics, La Trobe University, Melbourne, Victoria, Australia. · Department of Pathology, GZA Ziekenhuizen, Antwerp, Belgium. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Surgery Royal Melbourne Hospital and Royal Womens' Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Melbourne, Victoria, Australia. · Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 29942092
  • Dimitrios Zardavas and Debora Fumagalli, Breast International Group · Christos Sotiriou, Université Libre de Bruxelles, Brussels, Belgium · Luc te Marvelde and Roger L. Milne, Cancer Council · Roger L. Milne and Sherene Loi, University of Melbourne, Melbourne · Barry Iacopetta, University of Western Australia, Western Australia · Sandra O'Toole and Elena Lopez-Knowles, Garvan Institute of Medical Research, Darlinghurst, Australia · George Fountzilas and Vassiliki Kotoula, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki · Evangelia Razis, Hygeia Hospital · George Papaxoinis, Hippokration Hospital, Athens, Greece · Heikki Joensuu, Helsinki University Hospital and University of Helsinki, Helsinki, Finland · Mary Ellen Moynahan, Memorial Sloan Kettering Cancer Center, New York, NY · Bryan T. Hennessy, Beaumont Hospital and Royal College of Surgeons, Dublin, Ireland · Ivan Bieche, Curie Institut, Paris · Thomas Bachelot, Centre de Recherche en Cancérologie de Lyon, Lyon · Stefan Michiels, Gustave Roussy and Inserm, Univ. Paris-Sud, Univ. Paris-Saclay, Villejuif, France · Lao H. Saal, Lund University, Lund · Olle Stal, Qing Wang, and Gizeh Perez-Tenorio, Linköping University, Linköping, Sweden · Jeanette Dupont Jensen, University of Southern Denmark, on behalf of the Danish Breast Cancer Cooperative Group, Odense, Denmark · Elena Lopez-Knowles, Royal Marsden NHS Trust and Institute of Cancer Research, London · Daniel W. Rea, University of Birmingham, Birmingham, United Kingdom · Mattia Barbaraeschi, Santa Chiara Hospital, Trento, Italy · Shinzaburo Noguchi, Osaka University, Osaka Japan · Hatem A. Azim Jr, American University of Beirut (AUB), Beirut, Lebanon · Enrique Lerma, Universitat Autònoma de Barcelona, Barcelona, Spain · Cornelis J.H. can de Velde, Leiden University Medical Center, Leiden, the Netherlands · Vicky Sabine, University of Guelph, Guelph · John M.S. Bartlett, Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Pubmed 29470143
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia; Department of Pathology/GZA, Antwerp, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 29233560
2017
  • Hospital Sirio Libanes, Adma Jafet St 91, 1308050 São Paulo, Brazil. · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Vall d'Hebron Institute of Oncology, Centro Cellex, Calle Natzaret 115-117, 08035 Barcelona, Spain. Electronic address: · European Institute of Oncology, Via Ripamonti 435, 20146 Milano, Italy. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Grattan Street 305, 3000 Melbourne, Australia. Electronic address: · Institute of Pathology, Charité Universitätsmedizin Berlin and German Cancer Consortium (DKTK), Campus Mitte, Charitéplatz 1, D-10117 Berlin, Germany. Electronic address: · Baselga Oncological Institute, Quiron Hospital, Plaça d'Alfonso Comín 5, 08023 Barcelona, Spain. Electronic address: · Ramon y Cajal University Hospital, Ctra. Colmenar Viejo km. 9, 100, 28034 Madrid, Spain; Baselga Institute of Oncology, Madrid, Spain. Electronic address: · Pubmed 29061314
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA Ziekenhuizen, Antwerp, Belgium. · University of Melbourne, Melbourne, VIC, Australia. · Pubmed 28824872
  • Peter MacCallum Cancer Centre, Melbourne, Australia. · Peter MacCallum Cancer Centre, Melbourne, Australia; University of Melbourne, Melbourne, Australia. Electronic address: · Pubmed 28668293
  • Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, 305 Grattan St, Melbourne, Victoria, 3000, Australia. · Sir Peter MacCallum, Department of Oncology, University of Melbourne, Parkville, 3010, Australia. · Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, 305 Grattan St, Melbourne, Victoria, 3000, Australia. · Sir Peter MacCallum, Department of Oncology, University of Melbourne, Parkville, 3010, Australia. · Pubmed 28534250
  • EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · EORTC, Medical Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Department of Medical Oncology, Institut Bergonié Unicancer, INSERM CIC1401, Bordeaux, France. Electronic address: · Western General Hospital, Edinburgh Cancer Centre, Crewe Road South, GB Edinburgh EH4 2XU, UK. Electronic address: · EORTC, Statistics Department, Avenue Emmanuel Mounier 83b11, 1200 Brussels, Belgium. Electronic address: · Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia. Electronic address: · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 28027521
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · Department of Pathology, GZA-Hospitals, Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Genentech, South San Francisco, CA, USA. · Roche Products, Welwyn, UK. · Oncology Biomarker Development, Roche, Basel, Switzerland. · Lombardi Comprehensive Cancer Centre, Georgetown University, Washington, DC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay, Villejuif, France. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 27964843
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Surgery, St. Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia. · Cancer Immunology Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 28947417
  • Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, 1000, Belgium. · Breast Cancer Research Program and Department of Medicine, Vanderbilt-Ingram Cancer Centre and Vanderbilt University Medical Centre, Nashville, TN, 37232, USA. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia. · Pubmed 28928458
  • Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. · Institut du Cancer de Montréal, Montréal, Québec, Canada. · Faculté de Pharmacie, Université de Montréal, Québec, Canada. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. · School of Medicine, University of Queensland, Herston, Queensland, Australia. · Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Québec, Canada. · Pubmed 28855210
  • Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia. · Cancer Immunology Program, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Department of Immunology, Monash University, Clayton, Victoria, Australia. · Garvan Institute of Medical Research, Darlinghurst, Sydney, Australia. · St. Vincent's Hospital, University of New South Wales, Darlinghurst, Sydney, Australia. · Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia. · Pubmed 28848054
  • Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. · Molecular Genetics of Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Immunotherapy Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, University of Melbourne, Parkville, Victoria, Australia. · Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. · Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Stem Cells and Cancer Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Parkville Integrated Familial Cancer Centre, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Victoria, Australia. · Department of Medicine, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28592566
  • Department of Pathology, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Department of Pathology, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Molecular Genomics Core, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Cancer Genomics Program, Peter MacCallum Cancer Centre, Grattan Street, Melbourne, VIC, Australia. · Translational Breast Cancer Research, The Kinghorn Cancer Centre and Garvan Institute of Medical Research, Darlinghurst, NSW, Australia. · Department of Anatomical Pathology, South Eastern Area Pathology Service, St George Hospital, Kogarah, NSW, Australia. · School of Medical Sciences, University of New South Wales, Kensington, NSW, Australia. · Discipline of Pathology, School of Medicine, University of Western Sydney, Campbelltown, NSW, Australia. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Cancer Pathology, Bosch Institute, University of Sydney, Camperdown, NSW, Australia. · Sydney Medical School, University of Sydney, Camperdown, NSW, Australia. · School of Medicine and UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Australia. · Breast Service, The Royal Melbourne and Royal Women's Hospitals, Parkville, VIC, Australia. · Department of Surgery, University of Melbourne, Grattan Street, Parkville, Melbourne, VIC, Australia. · Translational Genomics &Epigenomics Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia. · Pubmed 28338653
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Vic, Australia. Electronic address: · Pubmed 28049579
2016
  • Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Institut Jules Bordet, Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: · Pubmed 27481651
  • Charlotte Fribbens, Ben O'Leary, Sarah Hrebien, Isaac Garcia-Murillas, Matthew Beaney, Mitch Dowsett, and Nicholas C. Turner, Institute of Cancer Research · Charlotte Fribbens, Ben O'Leary, Stephen R.D. Johnston, and Nicholas C. Turner, Royal Marsden Hospital · Lucy Kilburn and Judith M. Bliss, The Institute of Cancer Research Clinical Trials and Statistics Unit, London, UK · Massimo Cristofanilli, Thomas Jefferson University, Philadelphia, PA · Fabrice Andre, Institut Gustave Roussy, Villejuif, France · Sherene Loi, University of Melbourne, Melbourne, Australia · Sibylle Loibl, German Breast Group, Neu-Isenburg, Germany · and John Jiang, Cynthia Huang Bartlett, and Maria Koehler, Pfizer, New York, NY. · Pubmed 27269946
  • Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Victoria, Australia. · Cancer Genomics Program, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · kConFab, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · UCL Cancer Institute, CRUK Lung Cancer Centre of Excellence, London, United Kingdom. · The Francis Crick Institute, London, United Kingdom. · University of Applied Sciences Koblenz, RheinAhrCampus Remagen, Department of Mathematics and Technology, Remagen, Germany. · Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, the University of Melbourne, Victoria, Australia. · Bioinformatics Division, Walter & Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. · Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia. · Pubmed 28027312
  • Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Victoria, Australia. · Service de Biostatistique et d'Epidemiologie, Gustave Roussy, Villejuif, France. INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France. · Department of Oncology, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. · Department of Oncology, Tampere University Hospital and Tampere University, Tampere, Finland. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia. · Pubmed 26744522
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, Department of Pathology, GZA Antwerp, Belgium. · Charité University and German Cancer Consortium (DKTK), Berlin, Germany. · Departments of Pathology and Medicine, Yale University, New Haven, Connecticut. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Foundation Medicine, Cambridge, Massachusetts. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Maine Medical Center Research Institute, Scarborough, Maine. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Pubmed 26515496
2015
  • Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. · Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia. · Pubmed 26300242
  • Department of Medical Oncology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · INSERM Unit U981, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, VIC 3002, Australia. · Department of Biostatistics and Epidemiology, Gustave Roussy and Université Paris Sud, 94800 Villejuif, France. · Department of Medical Oncology and INSERM U916, Institut Bergonié, 229 Cours de l'Argonne, 33000, Bordeaux, France. · Pubmed 26196250
  • Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium2Department of Pathology, Gasthuis Zusters Antwerpen Hospitals, Antwerp, Belgium. · Institute of Pathology, Charité-Universitätsmedizin, Berlin, Germany4German Cancer Consortium, Berlin, Germany. · Frontier Science (Scotland) Ltd, Grampian View, Kincraig, Kingussie, United Kingdom. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Val d'Hebron Institute of Oncology, Barcelona, Spain. · Breast European Adjuvant Study Team, Institut Jules Bordet, Brussels, Belgium. · Department of Obstetrics and Gynecology, Campus Kiel, University Hospital Kiel, Kiel, Germany. · GlaxoSmithKline Oncology, Collegeville, Pennsylvania. · Memorial Sloan-Kettering Cancer Center, New York, New York. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Centre de Recherche en Epidémiologie et Santé des Populations, INSERM U1018, Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Sud, Villejuif, France. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 26181252
  • BrEAST Data Centre, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Electronic address: · Division of Pathology, European Institute of Oncology, Milan, Italy. · Fertility and Procreation Unit, Department of Gynecology Oncology, European Institute of Oncology, Milan, Italy. · Division of Pathology, European Institute of Oncology, Milan, Italy; University of Milan, School of Medicine, Milan, Italy. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 25702955
  • Peter MacCallum Cancer Centre, University of Melbourne, East Melbourne, Victoria, Australia · Pubmed 25753442
2013
  • Translational Breast Cancer Genomics Lab; Cancer Therapeutics Program; Peter MacCallum Cancer Centre; St. Andrews Place; East Melbourne, VIC Australia ; Sir Peter MacCallum Department of Oncology; University of Melbourne; Parkville, VIC Australia. · Pubmed 24073365
2018
  • From the Institute of Cancer Research and Royal Marsden Hospital, London (N.C.T.) · David Geffen School of Medicine at University of California, Los Angeles, Santa Monica (D.J.S.), and Pfizer Oncology, San Diego (X.H.) - both in California · National Cancer Center, Goyang-si, Gyeonggi-do (J.R.), and Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul (S.-A.I.) - both in South Korea · Dnipropetrovsk Medical Academy, City Multiple-Discipline Clinical Hospital 4, Dnipropetrovsk, Ukraine (I.B.) · National Hospital Organization Osaka National Hospital, Osaka (N.M.), and Aichi Cancer Center Hospital, Nagoya (H.I.) - both in Japan · Istituto Europeo di Oncologia (M. Colleoni) and Pfizer Oncology (C.G.) - both in Milan · Abramson Cancer Center, University of Pennsylvania, Philadelphia (A.D.), and Pfizer Oncology, Collegeville (C.H.B.) - both in Pennsylvania · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S. Loi) · Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada (S.V.) · Brustzentrum der Universität München, Munich (N.H.), and the German Breast Group, Neu-Isenburg (S. Loibl) - both in Germany · Institut Gustave Roussy, Villejuif, France (F.A.) · Pfizer Oncology, Cambridge, MA (K.P.T.) · and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago (M. Cristofanilli). · Pubmed 30345905
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
2015
  • From Royal Marsden Hospital, London (N.C.T.) · National Cancer Center, Goyang-si, South Korea (J.R.) · Institut Gustave Roussy, Villejuif, France (F.A.) · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia (S. Loi) · Sunnybrook Odette Cancer Centre, Toronto (S.V.) · Aichi Cancer Center Hospital, Nagoya, Japan (H.I.) · Brustzentrum der Universität München, Munich (N.H.), and German Breast Group Forschungs, Neu-Isenburg (S. Loibl) - both in Germany · Pfizer, New York (C.H.B., M.K.), La Jolla, CA (K.Z., S.R.), and Milan (C.G.) · and Thomas Jefferson University, Philadelphia (M.C.). · Pubmed 26030518
Probable:    Vanderbilt University   Contact    
2017
  • From the Vanderbilt University Medical Center, Nashville, TN; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore; Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 28561712
2016
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Brussels, Department of Pathology, GZA Antwerp, Belgium. · Charité University and German Cancer Consortium (DKTK), Berlin, Germany. · Departments of Pathology and Medicine, Yale University, New Haven, Connecticut. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. · Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Foundation Medicine, Cambridge, Massachusetts. · Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. · Maine Medical Center Research Institute, Scarborough, Maine. · Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Cancer Biology, Vanderbilt University, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. Department of Medicine, Vanderbilt University, Nashville, Tennessee. · Pubmed 26515496
2017
  • Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ. · Pubmed 28777142
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 99 total) written by Sherene Loi about Breast Neoplasms:

  • Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer. 2020
  • Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy. 2019
  • ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia. 2019
  • Triple-negative breast cancer: recent treatment advances. 2019
  • Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial. 2019
  • Targeting immune pathways in breast cancer: review of the prognostic utility of TILs in early stage triple negative breast cancer (TNBC). 2019
  • Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2 2019
  • Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer: An Australian case series. 2019
  • Persistent Impairment in Cardiopulmonary Fitness after Breast Cancer Chemotherapy. 2019
  • Molecular comparison of interval and screen-detected breast cancers. 2019
Show List of Full Article Records
Public Errors
Google Searches

Learn more about Sherene Loi using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Peter MacCallum Cancer Centre
University of Melbourne
Vanderbilt University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Peter MacCallum Cancer Centre
2020
  • Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. · Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel. · Department of Pathology, GZA-ZNA, Antwerp, Belgium. · Division of Research, Peter Mac Callum Cancer Center, Melbourne, Australia. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Medical Oncology Department, AC Camargo Cancer Center, São Paulo, Brazil. · Sharett Institute of Oncology, Hadassah Hebrew University Medical Center, Jerusalem, Israel. · German Breast Group, Neu-Isenburg and Goethe University Frankfurt and Centre for Haematology and Oncology, Bethanien, Frankfurt, Germany. · Institute of Pathology, Philipps-University Marburg and UKGM Marburg, Marburg, Germany. · Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. · Data Management Unit, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Molecular Immunology Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Oncology, University of Tampere and Tampere University Hospital, Tampere, Finland. · Department of Computer Science, Ariel University, Ariel, Israel. · Peter MacCallum Cancer Centre, University of Melbourne, Parkville, Victoria, Australia. · Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP U108, University Paris-Sud, University Paris-Saclay, Villejuif, France. · Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium. · Institut Jules Bordet, Université Libre de Bruxelles, Belgium. · Pubmed 31904863
2019
  • Peter MacCallum Cancer Centre, Melbourne, Australia. · Pubmed 31384388
  • SA Pathology, Royal Adelaide Hospital, Adelaide, SA, Australia. Electronic address: · Western Sydney University, and Australian Clinical Labs, Sydney, NSW, Australia. · ACT Pathology, Canberra Hospital, and ANU Medical School, Canberra, ACT, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, and the University of Melbourne, Melbourne, Vic, Australia. · The University of Queensland Centre for Clinical Research, and Pathology Queensland Research, Brisbane, Qld, Australia. · Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Vic, Australia. · Medical Oncology, Deakin University, Vic, Australia. · Surgical Oncology, The University of Sydney, and Mater Hospital North Sydney, Sydney, NSW, Australia. · Pubmed 31076089
  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Pubmed 31448088
  • Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132, Genova, Italy. · Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy. · Frontier Science, Kingussie, UK. · Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA, USA. · IEO, European Institute of Oncology IRCCS, University of Milan, Milan, Italy. · Mayo Clinic, Phoenix, AZ, USA. · Breast International Group, Brussels, Belgium. · National Cancer Institute, Bethesda, MD, USA. · Novartis Pharma AG, Basel, Switzerland. · Mayo Clinic, Jacksonville, FL, USA. · Sana Klinikum Offenbach, Offenbach, Germany. · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. · Institut Gustave Roussy, Villejuif, France. · Champalimaud Clinical Center, Champalimaud Foundation and Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. · Department of Medical Oncology, Hospital Clínic of Barcelona, Barcelona, Spain. · Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. · Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia. · Pubmed 31134488
  • Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; University of Melbourne, Melbourne, VIC, Australia. Electronic address: · Pubmed 31839159
  • Matrix Microenvironment & Metastasis Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, VIC, 3084, Australia. · School of Cancer Medicine, La Trobe University, Bundoora, VIC, 3086, Australia. · Metastasis Research Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia. · Metastasis Research Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Florey Institute of Neuroscience and Mental Health, Parkville, VIC, 3052, Australia. · Puma Biotechnology, Inc., 10880 Wilshire Blvd, Los Angeles, CA, 90024, USA. · Translational Breast Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, 3000, Australia. · Peter MacCallum Cancer Centre, Moorabbin Campus, East Bentleigh, VIC, 3165, Australia. · Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, 3000, Australia. · Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, 3000, Australia. · Royal College of Surgeons, Dublin, D02 YN77, Ireland. · Tumour Progression and Heterogeneity Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, 3084, Australia. · Molecular Medicine Division, The Walter and ELIZA Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. · Department of Medical Biology, The University of Melbourne, Melbourne, VIC, 3010, Australia. · Matrix Microenvironment & Metastasis Laboratory, Olivia Newton-John Cancer Research Institute, 145 Studley Road, Heidelberg, VIC, 3084, Australia. · School of Cancer Medicine, La Trobe University, Bundoora, VIC, 3086, Australia. · Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, 3000, Australia. · Pubmed 31409375
  • Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. · Ballarat Health Services, Ballarat, VIC, Australia. · St George Private Hospital, Kogarah, NSW, Australia. · St George Hospital and Sutherland Hospitals, Kogarah, NSW, Australia. · Royal Hobart Hospital, Hobart, TAS, Australia. · The Canberra Hospital, Woden, ACT 2606 and Australian National University Medical School, Garran, ACT, Australia. · Western Private Hospital, Footscray, VIC, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia. · Pubmed 31321873
  • Department of Sports Cardiology, Baker Heart and Diabetes Institute, Melbourne VIC, AUSTRALIA. · Institute for Physical Activity and Nutrition, Deakin University, Geelong, VIC, AUSTRALIA. · Exercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne VIC, AUSTRALIA. · Melbourne Cancer Care, Cabrini Health, Brighton, VIC, AUSTRALIA. · Translational Breast Cancer Genomics Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, AUSTRALIA. · Department of Cardiovascular Sciences, KU Leuven, Leuven, BELGIUM. · Integrated Cardiovascular Exercise Physiology and Rehabilitation (iCARE) Laboratory, College of Nursing and Health Innovation, University of Texas Arlington, Arlington, TX. · Cardiology Department, St Vincent's Hospital Melbourne, Melbourne VIC, AUSTRALIA. · Pubmed 30829962
  • Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. · Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia. · The Royal Melbourne and Royal Women's Hospitals, Parkville, Victoria, Australia. · The Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Bioinformatics Consulting Core, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Genomics Core, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Department of Pathology, Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, Victoria, Australia. · Lifepool, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia. · Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia. · Cancer Genetics and Genomics Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. · Pubmed 30746706
  • 1 Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. · 2 Gustave Roussy, Université Paris-Saclay, Villejuif, France. · 3 Université Paris-Sud, Institut National de la Santé et de la Recherche Médicale, Villejuif, France. · 4 New York University School of Medicine, New York, NY. · 5 Fondazione Istituto di Ricovero e Cura a Carattere Scientifico-Isituto Nazionale dei Tumori, Universita degli Studi di Milano, Milan, Italy. · 7 Helsinki University Central Hospital, Helsinki, Finland. · 8 University of Padova, Padova, Italy. · 9 Veneto Insitute of Oncology-IOV-IRCCS, Padua, Italy. · 10 Indiana University, Indianapolis, IN. · 11 Weill-Cornell Medicine, New York, NY. · 12 Dana-Farber Cancer Institute, Boston, MA. · 13 European institute of Oncology, Milan, Italy. · 6 R&D UNICANCER, Paris, France. · 14 Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · 15 Tampere University Hospital, Tampere, Finland. · 16 University of Milan, Milan, Italy. · 17 Charite Universite Hospital, Berlin, Germany. · 18 GZA, Antwerp, Belgium. · Pubmed 30650045
  • Cancer Care Centre, St George Hospital, Sydney, NSW, Australia. · National Health and Medical Research Council (NHM